A biopharmaceutical company has sold the site of its headquarters in Newark, a well-known office tower spanning nearly 500,000 square feet, in a deal valued at more than $49 million.
An investment firm has reaped nearly $4 million from the sale of a Piscataway office building, following a transaction arranged by brokers with Colliers International.
